Ameriprise Financial Inc. Purchases 6,044 Shares of Amedisys Inc (AMED)
Ameriprise Financial Inc. raised its position in Amedisys Inc (NASDAQ:AMED) by 3.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 177,536 shares of the health services provider’s stock after purchasing an additional 6,044 shares during the quarter. Ameriprise Financial Inc. owned 0.52% of Amedisys worth $9,934,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AMED. Riverhead Capital Management LLC grew its holdings in shares of Amedisys by 75.5% in the 2nd quarter. Riverhead Capital Management LLC now owns 1,931 shares of the health services provider’s stock valued at $121,000 after acquiring an additional 831 shares in the last quarter. Federated Investors Inc. PA grew its holdings in shares of Amedisys by 2.3% in the 2nd quarter. Federated Investors Inc. PA now owns 1,929 shares of the health services provider’s stock valued at $122,000 after acquiring an additional 44 shares in the last quarter. Quantitative Systematic Strategies LLC bought a new position in shares of Amedisys in the 3rd quarter valued at about $205,000. SG Americas Securities LLC grew its holdings in shares of Amedisys by 48.7% in the 2nd quarter. SG Americas Securities LLC now owns 3,743 shares of the health services provider’s stock valued at $235,000 after acquiring an additional 1,226 shares in the last quarter. Finally, Amalgamated Bank bought a new position in shares of Amedisys in the 2nd quarter valued at about $246,000. 94.44% of the stock is currently owned by hedge funds and other institutional investors.
Amedisys Inc (NASDAQ:AMED) opened at $52.25 on Thursday. Amedisys Inc has a 1-year low of $42.05 and a 1-year high of $65.91. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16. The company has a market capitalization of $1,780.00, a PE ratio of 24.92, a P/E/G ratio of 1.26 and a beta of 0.70.
Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Tuesday, November 7th. The health services provider reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.02. Amedisys had a return on equity of 14.68% and a net margin of 2.88%. The business had revenue of $380.20 million during the quarter, compared to analysts’ expectations of $384.59 million. During the same quarter last year, the company posted $0.36 earnings per share. Amedisys’s quarterly revenue was up 5.1% on a year-over-year basis. analysts forecast that Amedisys Inc will post 2.23 EPS for the current fiscal year.
AMED has been the subject of several analyst reports. SunTrust Banks restated a “buy” rating and issued a $60.00 price objective on shares of Amedisys in a report on Monday, October 9th. Royal Bank of Canada reiterated a “hold” rating on shares of Amedisys in a report on Monday, October 23rd. Robert W. Baird lifted their price target on Amedisys from $50.00 to $60.00 and gave the stock a “neutral” rating in a report on Friday, November 10th. Jefferies Group reiterated a “buy” rating and set a $60.00 price target on shares of Amedisys in a report on Thursday, October 12th. Finally, William Blair reiterated an “outperform” rating on shares of Amedisys in a report on Tuesday, November 21st. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $61.00.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.watchlistnews.com/ameriprise-financial-inc-purchases-6044-shares-of-amedisys-inc-amed/1775519.html.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.